Translation of "translation of nom usager " (French → English) :

Moreover, there was no evidence that the word sign IP TRANSLATOR had acquired a distinctive character through use in relation to translation services prior to the date of the application for registration.

EUROPA - EU law and publications - EUR-Lex - EUR-Lex - 32010R1235R(01) - EN - Corrigendum to Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products ( OJ L 348, 31.12.2010 ) // Corrigendum to Regulation (EU) No 1235/2010 of the European Parliament and of the Cou ...[+++]ncil of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products - Official Journal of the European Union L 348 of 31 December 2010

(a)if, within a continuous period of five years, the trade mark has not been put to genuine use in the ►M1 Union ◄ in connection with the goods or services in respect of which it is registered, and there are no proper reasons for non-use; however, no person may claim that the proprietor's rights in an►M1 EU trade mark ◄ should be revoked where, during the interval between expiry of the five-year period and filing of the application or counterclaim, genuine use of the trade mark has been started or resumed; the commencement or resumption of use within a period of three months preceding the filing of the application or counterclaim which began at the earliest on expiry of the continuous period of five years of non-use shall, however, be disregar ...[+++]ded where preparations for the commencement or resumption occur only after the proprietor becomes aware that the application or counterclaim may be filed.

a new expert committee, within the European Medicines Agency to assess and agree companies’ testing plans; a requirement at the time of marketing authorisation applications for data on the use of the medicine in children (plus a system of waivers from this requirement for medicines unlikely to benefit children and a system of deferrals to ensure medicines are tested in children only when it is safe to do so and to ensure the requirements do not delay the authorisation of medicines for adults); a reward for studying medicines for c ...[+++]hildren of 6-months extension to the supplementary protection certificate - in effect, six-month patent extension; for off-patent medicines, ten-years of data protection for new studies awarded via a Paediatric Use Marketing Authorisation (P.U.M.A); increased safety monitoring for children’s medicines and compulsory submission by industry of existing studies in children; an EU inventory of the therapeutic needs of children and an EU network of investigators and trial centres to conduct the studies required; a system of free scientific advice for the industry, provided by the European Medicines Agency.

The following situations or cases have been identified: 1) A Kommanditgesellschaft that uses the special depreciation and the 125% loss deduction of taxable income; 2) A Kommanditgesellschaft that uses the normal degressive depreciation and the 125% loss deduction of taxable income; 3) A non-Kommanditgesellschaft, that is in general but not necessarily a Kapitalgesellschaft (AG, GmbH), that uses the special depreciation; 4) A one-ship-company that is not a Kommanditgesellschaft, that uses the special depreciation.

Tolls may include a charge for external costs of up to 0.03 ecu per km. User Set a maximum Specifies maximum user Charges level for annual charge levels for 3 user charges and vehicle damage required shorter categories and 3 period charges to emission levels. be made Requires shorter period available. charges to be made available and specifies the ratio of charges for different time periods.